RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, Tablet (vial): 1mg/vial

As a manufacturer of biomedical materials, we are proud to present our latest breakthrough product, Recombinant Human Bone Morphogenetic Protein-2 (RhBMP-2). This innovative implantable medical device is designed to stimulate bone growth and repair, offering a new and effective treatment option for patients with bone fractures, deformities, or other injuries.

RhBMP-2 is a protein molecule that plays a crucial role in the development and maintenance of bone tissue. It is a naturally occurring substance that has been synthesized and optimized for clinical use. The product is sold in tablet form, with each vial containing 1mg of the protein.

One of the key advantages of RhBMP-2 over other bone repair materials is its ability to promote the formation of new bone tissue, rather than simply filling in gaps or supporting existing bone. This is achieved by activating specific cells in the body that are responsible for bone growth and remodeling.

The benefits of RhBMP-2 are numerous and significant. For patients, it means faster and more complete healing of bone injuries, reducing pain and disability, improving quality of life, and lowering the risk of complications or repeated surgeries. For healthcare providers, it means a more effective and efficient way of treating bone injuries, reducing hospital stays, and improving outcomes.

We take pride in the quality and safety of our products. RhBMP-2 is manufactured using state-of-the-art techniques and strict quality control measures to ensure purity, potency, and consistency. The product is registered as an implanted medical device, complying with all relevant regulations and standards.

We are committed to providing our customers with the best possible service and support. Our team of experts is available to answer any questions, provide technical assistance, and help with customization and supply chain management.

We believe that RhBMP-2 represents a major advancement in the field of bone repair and regeneration. It has the potential to transform the way we treat bone injuries and improve patient outcomes around the world. If you are a merchant looking for a high-quality, innovative, and effective bone repair material, RhBMP-2 is the product for you. Contact us today to learn more and place an order.

Structural Component: The product is using recombinant human bone morphogenetic protein-2 (rhBMP-2) as the active ingredient and using medical gelatin, soy lecithin and hydroxyapatite as the carrier materials. It is of sterile packaging.

Product Property: The product can induce directional differentiation of intracorporal mesenchymal stem cells into osteoblasts, after filled at the defect area of bone tissue, osteogenesis can be induced to stimulate the formation of bone and cartilage, so as to achieve tissue repair. It could be degraded and absorbed by the body.

Indications: The product is indicated for fill repair of bony defects, bone nonunion, bone delayed union, and graft repair of spinal fusion, joint fusion, and orthopedic bone graft.

Instructions for Use: The implantation dose of the product must be determined by orthopaedic surgeons with professional knowledge and the dosage should depend on the specific condition and size of trauma or defected area. The recommended dose for one single part is 4-6mg of rhBMP-2; the maximum dosage for one single use is 6mg of rhBMP-2. The product can be used alone or combined with other conventional therapy. If the defect is large, the product can be used in combination with autogenous/allogenous graft or other degradable grafting materials.

Contraindications:

1. The product is contraindicated for the patients with severe cardiac or renal insufficiency, liver function impairment and hematopoietic dysfunction.

2. The product should not be used in patients with the history of malignant tumors.

3. The product should be used with caution in patients needing systemic application of glucocorticoids.

4. The product should be used with caution in patients with metabolic bone disease.

5. The product should be used with caution in pregnant women, nursing mothers and children.

[Name]

Chemical Name: Recombinant Human Bone Morphogenetic Protein-2

A new type bone repairing material which has biological activity.

Specification: 0.3mg rhBMP-2/vial, 0.4mg rhBMP-2/vial, 0.4mg-Ⅰ rhBMP-2/vial, 0.5mg-ⅠrhBMP-2/vial, 0.5mg-ⅡrhBMP-2/vial, 0.6mg rhBMP-2/vial, 0.6mg-ⅠrhBMP-2/vial, 0.75mg rhBMP-2/vial, 0.8mg rhBMP-2/vial, 0.8 mg-ⅠrhBMP-2/vial, 1.0mg rhBMP-2/vial, 1.0mg-ⅠrhBMP-2/vial, 1.2mg rhBMP-2/vial, 1.5mg rhBMP-2/vial, 1.6mg rhBMP-2/vial, 2.0mg rhBMP-2/vial, 2.4mg rhBMP-2/vial, 3.0 mg rhBMP-2/vial

[Indication]

Indicated in filling and repairing for various reasons caused bone defect, bone non-union, delayed bone healing or unhealing, as well as treated in spinal fusion, joint fusion and orthopedic bone graft repair.

Hangzhou Jiuyuan is a top-biotech joint venture specializing in the research, development, manufacture, and marketing of pharmaceuticals based on gene engineering and biochemical technology since 1993. It has gene engineering workshops, injection workshops, pharmaceutical API workshops, and other sections including the quality management department, warehouse, engineering department, etc., all of which are built according to GMP requirements. Jiuyuan is equipped with advanced production and analysis instruments like chromatography systems, HPLC, and capillary electrophoresis. We offer high-quality products and comprehensive sales services, please contact us.

Company Profile

Hangzhou Jiuyuan Gene Engineering Co., Ltd. is a modern biopharmaceutical company, specializing in R&D, manufacture, and sales of gene engineering, biochemical, chemical drugs, and medical device. The company was founded in December 1993 as a member of Huadong Medicine Group and became one of the earliest gene engineering pharmaceutical enterprises in Zhejiang province as well as in China.

The company always upholds the concept "Taking gene engineering as orientation, Rendering service to human health", to pursue innovation and to strive for excellence. In October 1996, the company took the lead in the successful development and industrialization of a leukocyte promotion medicine named JILIFEN (Filgrastim, rhG-CSF), entered the market monopolized by the U.S and Japanese manufacturers and won the praise of "First Injection in China". Over the twenty years, the company has actively propelled the progress of biopharmaceutical industrialization, gradually developed a series of products including JILIFEN, JIPAILIN, JIJUFEN, YINUOJIA, JIOUTING and GUYOUDAO, and so on.

In 2020, the R&D center and part of the production line have moved to Hangzhou Medicine Valley, the level of software and hardware in R&D and production have been improved. With the help of the Academician expert station, postdoctoral workstation, and other scientific research platforms, Jiuyuan devoted all the efforts to developing macromolecular drugs of insulin and monoclonal antibody. The company successively acquired various honors like National New High-tech Enterprise, Key New High-tech Enterprise of National Torch Plan, Second Class Prize of Provincial Scientific-technical Progress, Provincial Famous Trademark, Provincial High-tech Research and Development Center, and so on.

Company Honor

National New High-tech Enterprise

Key New High-tech Enterprise of National Torch Plan

National superior enterprise of intellectual property

Provincial New High-tech Research & Development Center

Zhejiang Provincial Enterprise Technology Center

Zhejiang Famous Trademark

Zhejiang Jiuyuan Gene Engineering Biopharmaceutical Research Institute

Zhejiang province per mu benefit leading enterprises

Gene-engineering New Drug R&D Technology and Service Sub-platform

Provincial Post-doctoral Scientific Research Working Center

Excellent industrial products in Zhejiang Province

Hangzhou Academician Expert Working Center

Hangzhou Top Ten New High-tech Enterprise

Zhejiang Green Enterprise

What is your advantage compared with your competitors?

(1). Qualified Manufacturer

(2). Reliable Quality Control

(3). Competitive Price

(4). High-Efficiency working (24*7hours)

(5). One-Stop Service

Our Services

1. Good knowledge on different market can meet special requirements.

2. Real manufacturer with our own factory located in China

3. Strong professional technical team ensure to produce the top quality products.

4. Special cost control system ensure to provide the most favorable price.

5. Rich experience on drug.

Why choose us?

• Our Medical Device products are approved by regulatory bodies and meet industry standards.
• We continue to build a new advantage of RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, Tablet (vial): 1mg/vial service provider with social respect, significant benefits and sustainable development.
• We offer customization options for our customers who have unique requirements.
• Our company will focus on the development strategy of "creating a well-known brand", and form the company's own advantages in product performance and price, marketing system, after-sales service, and corporate culture. We keep improving the quality of RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material， Registered As An Implanted Medical Device, Tablet (vial): 1mg/vial, because only in this way can we participate in the international market, broaden the domestic market, and achieve long-term development.
• Our prices are competitive and cost-effective for our customers.
• Our talent concept is to make the best use of people and talents, to provide a guarantee for the rapid growth and efficient operation of our company.
• Our Medical Device products are always aimed at enhancing patient care and recovery.
• The long-term emphasis on talent has created a team of employees with comprehensive business capabilities, superb technical strength and strong service awareness to ensure that our products always occupy an important position in the market.
• We are committed to delivering top-quality Medical Device products.
• Our market philosophy is that there is no weak market, only a lack of positive innovation.

Hot Tags: rhbmp-2 (recombinant human bone morphogenetic protein-2) – a new bone repair material， registered as an implanted medical device, tablet (vial): 1mg/vial, China rhbmp-2 (recombinant human bone morphogenetic protein-2) – a new bone repair material， registered as an implanted medical device, tablet (vial): 1mg/vial manufacturers, suppliers, factory, cochlear implant, surgical gown, endoscope, autoclave, absorbable suture, retainer